|
|
||||||||
J Thorac Cardiovasc Surg 2008;136:1187-1192
© 2008 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Department of Cardiovascular Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea
b Department of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea
c Department of Preventive Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea
Received for publication December 13, 2007; revisions received July 13, 2008; accepted for publication August 5, 2008. * Address for reprints: Hyun Song, MD, Department of Cardiovascular Surgery, Asan Medical Center, University of Ulsan, College of Medicine, 388-1 Poongnap2-dong, Songpa-gu, Seoul 138-736, South Korea. (Email: cs3580{at}amc.seoul.kr).
| Abstract |
|---|
|
|
|---|
Methods: The study retrospectively analyzed 250 patients (86 men, 164 women) with mild functional tricuspid regurgitation (grade 2) who had mitral valve surgery between January 1994 and July 2006. Based on follow-up data, patients were defined as either stable (n = 209, 83.6%) or aggravated (n = 41, 16.4%). Predictors for significant tricuspid regurgitation development were identified using Cox regression analysis.
Results: The mean follow-up time was 62.6 ± 39.8 months after surgery. Although most mitral valve procedures were successful, there was an increase in the incidence of significant functional tricuspid regurgitation overall from immediately postoperative to final assessment (5.2% to 16.4%, P < 0.01). Univariate analysis showed that old age, shorter aortic crossclamping time, and omission of Maze operation were associated with functional tricuspid regurgitation progression. Multivariate analysis showed that older age (adjusted hazard ratio, 1.05; 95% confidence interval, 1.02 to 1.08), a rheumatic etiology of the mitral valve disease (adjusted hazard ratio, 2.31; 95% confidence interval, 1.21 to 4.42), and no Maze operation (adjusted hazard ratio, 7.90; 95% confidence interval, 1.90 to 32.86) were independent predictors of mild functional tricuspid regurgitation progression. For the 168 patients with preoperative atrial fibrillation, Maze operation improved the tricuspid regurgitation–free survival significantly (P < .01) but tricuspid valve repair showed no significant difference.
Conclusions: Mild functional tricuspid regurgitation can progress postoperatively despite successful mitral valve surgery. Although tricuspid valve repairs alleviate progression of functional tricuspid regurgitation, concomitant Maze operation is a more powerful protective factor against mild functional tricuspid regurgitation progression.
| Introduction |
|---|
|
|
|---|
The fate, risk factors, and surgical indications for FTR after mitral and/or aortic valve surgery have been reported.5-8
Moderate to severe FTR is generally corrected during MV surgery as significant FTR can increase mortality and morbidity. However, for the mild FTR, the decision to perform surgery remains debatable in terms of when and how to treat the tricuspid valve (TV). Although it is not uncommon to encounter a patient with MV disease and mild FTR, relatively few clinical studies provide information that might assist in managing this situation. To our knowledge, no studies have investigated surgical outcomes in patients with mild FTR exclusively.
Several surgical options for FTR-associated MV disease have been reported, including MV surgery,1
which expects to improve FTR as the result of its performance, aggressive TV repair to prevent TR progression even when the initial TR was mild,6
and MV surgery with a Maze operation (MAZE) to prevent progression of functional TR.9
We hypothesize that concomitant MAZE and TV repair can prevent progression of mild FTR in patients having MV surgery.
The present study analyzed surgical outcomes in patients with mild FTR having MV surgery. The study examined the effect of MAZE and TV repair on postoperative TR progression. The study also sought to identify factors associated with TR progression that may act as indicators for concomitant surgical treatment of patients with mild FTR having MV surgery.
| Materials and Methods |
|---|
|
|
|---|
Echocardiographic Evaluation
Transthoracic echocardiographic evaluation was performed before and after surgery, and then annually during follow-up. Two-dimensional echocardiography and Doppler color flow imaging were performed on all patients using a Hewlett-Packard Sonos 2500 or 5500 imaging system equipped with a 2.5-MHz transducer (Hewlett-Packard, Andover, Mass). Preoperative transesophageal echocardiography was routinely performed to evaluate MV morphology.
TR was evaluated using the apical 4-chamber view. TR was graded as trace, mild, moderate, or severe when the jet area occupied <10%, 10% to 20%, 20% to 33%, or >33% of the right atrial area, respectively. During the follow-up, development of moderate to severe TR was defined as significant TR and was also termed "aggravated FTR." Postoperative improvement or maintenance of preoperative mild FTR was defined as "stable FTR." Based on these definitions, there were 209 (83.6%) patients with stable FTR and 41 (16.4%) patients with aggravated FTR. Right ventricular systolic pressures were estimated using continuous-wave Doppler data and the simplified Bernoulli equation (4 x [peak TR velocity]2) with 10 mm Hg added for the estimated right atrial pressure.10
Residual mitral regurgitation (MR) was defined as more than mild MR at follow-up echocardiography, and residual MS was defined as less than 1.5 cm2 of the MV area during follow-up.
Surgical Procedures
All patients had MV surgery without aortic valve or coronary surgery. MV replacement was performed in 147 patients (58.8%) and MV repair in 103 (41.2%) patients. MV replacement involved bileaflet mechanical prostheses (n = 127, 86.4%) or bioprostheses (n = 20, 13.6%). MV repair was attempted whenever MV pathology was favorable, and MV replacement was performed only when the MV was severely destructed or MV repair was unsatisfactory on intraoperative transesophageal echocardiography. A median sternotomy approach was used for most patients (225, 90%) and a right anterolateral minithoracotomy approach using the AESOP 3000 system (Computer Motion, Inc., Santa Barbara, CA) was used in the most recent 25 (10%) patients. The recent minimally invasive approach has several advantages such as stable thoracoscopic view, easily controlled with surgeon's voice, and reduction of one surgical assistant. Conventional ascending aorta and bicaval cannulation was used for the sternotomy approach, and the minimally invasive approach involved peripheral cannulation via the right internal jugular vein, right femoral vein, and right femoral artery.
TV repair was performed in 82 (32.8%) patients. Of those, 55 (22.0%) had suture annuloplasty and 27 (10.8%) had ring annuloplasty. The decision to perform a TV repair and the choice of repair technique was at the attending surgeon's discretion; ring annuloplasty was generally used for more severe tricuspid annular dilatation. Ring annuloplasty involved a Carpentier ring (Edwards Lifesciences, Irvine, Calif) in 4 patients and a Duran ring (Medtronic, Minneapolis, Minn) in 23 patients, and the most common ring size was 27 mm. Kay annuloplasty (bicuspidalization) or a De Vega procedure (from the anteroseptal to the posteroseptal commissure) was performed for suture annuloplasty according to surgeon preference.
Concomitant procedures consisted of MAZE in 73 (29.2%) patients, atrial septal defect repair in 7 patients, and left atrial myxoma resection in 2 patients. Five patients had a history of percutaneous mitral valvuloplasty. Among 73 MAZE procedures, between 1997 and 1998, 2 patients had a classic cut-and-sew Cox-Maze III, and since 1998, 71 patients had simplified MAZE, which was modified by the authors.11
As MAZE has been performed since 1997 and its application was totally at the surgeon's discretion, only a small number of patients had the MAZE in this study. Recently, the MAZE was rather generally performed to treat atrial fibrillation (AF) in our institution; however, some authors in this study have been prudent to perform a MAZE especially in conjunction with MV replacement using a mechanical prosthesis.
Thirty-eight (15.2%) patients had previous cardiac surgery.
Clinical Follow-up
Clinical follow-up ranged from 12 to 160 months. Data were obtained during visits to the outpatient clinic or by telephone interview. Patient clinical status and echocardiographic results were obtained from cardiologists at our institute. Patients had an echocardiography assessment during the week after surgery, at postoperative 6 months, and then annually during follow-up. Because patients who had echocardiographic follow-up at local clinics were excluded from the study design, a complete echocardiogram follow-up could be achieved in these study populations. Normal sinus rhythm restoration after MAZE was defined as a presence of transmitral A-wave at the last echocardiographic follow-up.
Statistical Analysis
Continuous variables are presented as mean ± standard deviation, and categorical variables as percentages or numbers. For univariate analyses, preoperative and operative variables were analyzed using the Kaplan-Meier method or the Cox regression model to investigate the influence of these variables on FTR progression during follow-up. The difference of significant TR development at the immediate postoperative period, at postoperative 1 year, and the most recent follow-up was assessed using McNemar's test. Independent predictors were determined using Cox's multivariable analysis involving a backward elimination procedure. The proportional hazards assumption was confirmed by examination of log (–log [survival]) curves and by testing partial (Schoenfeld) residuals,12
and no relevant violations were found. All P values were 2-sided. Statistical analysis was performed using SPSS version 12.0 for Windows (SPSS Inc, Chicago, Ill).
Declaration
All authors had full access to the data and take responsibility for its integrity. All authors have read the manuscript and accept the contents.
| Results |
|---|
|
|
|---|
|
Among the 250 patients who enrolled in this study, 9 patients (3.6%) had reoperation for bleeding, 5 patients (2.0%) had minor sternal wound problems, and 3 patients (1.2%) needed pericardial drainage for severe pericardial effusion. A permanent pacemaker was inserted in 2.7% (2/73) of patients who showed sick sinus syndrome after the MAZE.
Reoperations and Long-Term Clinical Outcomes
The mean follow-up time was 62.6 ± 39.8 months (range 12.0 to 160.3). During the follow-up period, only 3 reoperations were required, and these involved correction for severely aggravated TR. The incidences of residual mitral regurgitation and residual mitral stenosis were similar between the stable and aggravated groups (Table 2
). Although 9 of the 13 patients with residual MR had moderate MR and 4 of them had severe MR, all patients responded well to medical treatment. Two residual MR cases and 3 residual MS cases were the result of structural deterioration of a bioprosthesis. Only 1 reoperation for an MV was required, and this was in a patient who had mitral annuloplasty with a Duran ring. That patient had a reoperation for severe MS with severe TR at 82 months after the initial operation. Compared with the stable group, the aggravated group had a lower left ventricular ejection fraction, bigger left atrium size, higher systolic pulmonary artery pressure, and greater prevalence of atrial fibrillation on the most recent echocardiographic examination (Table 2).
|
|
|
Risk Factor Analysis of Late Significant TR
The crude relative risks of FTR progression in terms of preoperative and operative variables are shown in Table 3
. Univariate analysis showed FTR progression was associated with elderly patients, shorter ACC time, and omission of MAZE. The effect of preoperative atrial fibrillation, MV replacement (compared with repair), and no TV repair approached but did not quite reach significance in univariate analysis (Table 3). Multivariate analysis showed that older age, a rheumatic etiology of the MV disease, and no MAZE were independent predictors of FTR aggravation after successful MV surgery (Table 3).
|
|
| Discussion |
|---|
|
|
|---|
Several reports suggest that TR can be regressive after successful mitral balloon valvuloplasty or surgery. It appears logical that significant FTR could be resolved if the transmitral pressure gradient and pulmonary artery pressure were markedly lowered.2
This concept is supported by findings that minimal right atrium (RA) enlargement and +1 to +2 regurgitation usually resolves after surgery on left-sided valve lesions, especially if the pulmonary hypertension resolves.13
In contrast, other studies reported that FTR could be progressive and should be treated even if preoperative TR is mild or grade II.6,14
In the present study, although only 5.2% of patients showed significant TR at the immediate postoperative echocardiography assessment, this number increased to 16.4% at the final follow-up. This finding suggests that TR can be progressive despite MV pathology being relieved.
Although some studies conclude ring annuloplasty is superior to suture annuloplasty for TR repair,15
others recommend ring annuloplasty for severe TR and suture annuloplasty for mild to moderate TR.14
In the present study, patients having ring annuloplasty and patients having suture annuloplasty showed similar postoperative significant TR development rates. This may reflect that the present study population was exclusively patients with mild FTR and contained a small number of patients who had TR repair.
Previous studies identified several clinical and echocardiographic factors associated with development of late TR after left-sided valve surgery, such as atrial fibrillation, rheumatic etiology, older age, lower left ventricular ejection fraction, huge left atrium, and higher preoperative TR grade.6,16
Most risk factors for late FTR development are related to the chronic course of the left-sided valvular disease, and these chronic changes may contribute to irreversible changes to the tricuspid annulus and right ventricular function. The findings of the present study indicate that older age and a rheumatic etiology of the MV are strong predictors of significant TR progression after MV surgery even when the FTR is mild.
Because atrial fibrillation is a well-known risk factor for TR aggravation,6,9
a recent study suggested that sinus conversion resulting from MAZE can prevent FTR progression.9
In the present study, MAZE was found to be the most important predictor of FTR aggravation after MV surgery, and the incidence of significant TR progression by omission of MAZE increased 7.9 times. Although TV repair might alleviate mild FTR progression in patients with atrial fibrillation, MAZE had a more potent protective effect.
| Limitations |
|---|
|
|
|---|
| Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Garcia Fuster, A. Vazquez, A. G. Pelaez, E. Martin, S. Canovas, O. Gil, F. Hornero, and J. Martinez-Leon Factors for development of late significant tricuspid regurgitation after mitral valve replacement: the impact of subvalvular preservation Eur J Cardiothorac Surg, June 1, 2011; 39(6): 866 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Min, J.-M. Song, J.-H. Kim, M.-K. Jang, Y.-J. Kim, H. Song, D.-H. Kim, J. W. Lee, D.-H. Kang, and J.-K. Song Geometric changes after tricuspid annuloplasty and predictors of residual tricuspid regurgitation: a real-time three-dimensional echocardiography study Eur. Heart J., December 1, 2010; 31(23): 2871 - 2880. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., April 20, 2010; 55(16): 1729 - 1742. [Full Text] [PDF] |
||||
![]() |
J.-K. Song, M.-J. Kim, S.-C. Yun, S. J. Choo, J.-M. Song, H. Song, D.-H. Kang, C. H. Chung, D. W. Park, S. W. Lee, et al. Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery J. Thorac. Cardiovasc. Surg., January 1, 2010; 139(1): 103 - 110. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |